Atossa Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2011 | -220.7% | -220.7% | -112.1% |
| FY2012 | -98.2% | -98.2% | -74.4% |
| FY2013 | -101.7% | -101.7% | -89.8% |
| FY2014 | -154.3% | -153.5% | -124.6% |
| FY2015 | -421.2% | -421.2% | -252.4% |
| FY2016 | -205.6% | -205.6% | -153.7% |
| FY2017 | -117.1% | -117.1% | -99.5% |
| FY2018 | -129.5% | -129.5% | -97.3% |
| FY2019 | -131.0% | -131.0% | -119.0% |
| FY2020 | -65.6% | -65.6% | -41.6% |
| FY2021 | -14.9% | -14.9% | -14.6% |
| FY2022 | -22.9% | -22.9% | -21.8% |
| FY2023 | -33.1% | -33.1% | -31.3% |
| FY2024 | -35.7% | -35.7% | -33.4% |
| FY2025 | -88.4% | -88.4% | -73.0% |